You can be a normal weight, exercise several times a week, and still be quietly carrying a type of fat that raises your risk of heart disease, diabetes, and cancer.
That fat is called visceral adipose tissue, or VAT. And unlike the fat you can pinch, it doesn’t show up on a bathroom scale. It’s exactly the kind of thing a good concierge doctor in Las Vegas should be checking for, even when you feel perfectly healthy.
What Is Visceral Fat, and Why Should Your Concierge Doctor in Las Vegas Be Watching It?
Unlike subcutaneous fat sitting just under the skin, visceral fat wraps around the organs deep in the abdomen. Excess VAT is considered one of the strongest independent predictors of cardiometabolic disease. Meaning, it drives risk regardless of BMI or total body fat. Mendelian randomization studies have confirmed VAT as a causal risk factor for hypertension, coronary artery disease, type 2 diabetes, and hyperlipidemia.
The numbers are striking. A recent NHANES analysis found that people in the highest quartile of visceral fat had a 67% higher risk of all-cause mortality and nearly 3 times the risk of cardiometabolic mortality compared to those in the lowest quartile. It’s the kind of risk that’s easy to miss without the right screening. Which is exactly why more Las Vegas residents are turning to concierge medicine for a closer look.
The Health Risks a Concierge Doctor in Las Vegas Screens For
- Cardiovascular disease: VAT drives systemic and vascular inflammation and accelerates atherosclerosis, raising the risk of coronary artery disease, heart failure, atrial fibrillation, and blood clots.
- Type 2 diabetes: Visceral fat floods the liver with free fatty acids, impairing insulin function. The effect is especially strong in women, with a 7.34-fold increased risk of type 2 diabetes, compared to 2.50-fold in men.
- Fatty liver disease: VAT is the most common driver of hepatic steatosis, also known as NAFLD/MASLD.
- Cancer: In a UK Biobank study of more than 385,000 people, high visceral adiposity was linked to significantly elevated risk of uterine, gallbladder, kidney, colorectal, and breast cancers. In postmenopausal women, every 100 cm² increase in VAT raised obesity-related cancer risk by 32%, independent of BMI.
Why BMI and the Scale Don’t Tell the Full Story
Two people can share the exact same BMI and have very different levels of visceral fat….and very different risk profiles. This helps explain the so-called “obesity paradox,” in which mildly overweight patients sometimes appear healthier on paper. When visceral fat is measured directly, though, higher VAT consistently predicts worse outcomes. Waist circumference remains a reasonable clinical proxy, but it can’t reliably distinguish visceral fat from subcutaneous fat.
The Best Way to Actually Measure Visceral Fat, And Why a Concierge Doctor in Las Vegas Uses DEXA
This raises the obvious question: if the scale and BMI aren’t reliable, how do you actually find out how much visceral fat you’re carrying?
MRI is the reference standard for tracking precise changes in visceral fat over time, but repeated MRI scans take more time, are often cost-prohibitive for routine monitoring, and most insurance plans won’t cover them for this purpose. CT scans can also estimate VAT, but repeated CT scanning exposes patients to a meaningful, cumulative radiation dose that isn’t appropriate for ongoing monitoring.
That’s why a growing number of concierge doctors in Las Vegas rely on DEXA (dual-energy X-ray absorptiometry) scanning run through the correct, validated software platforms such as GE CoreScan or Hologic APEX – as the best practical option. These systems represent a meaningful advance over older DEXA technology and are endorsed by experts as the best non-MRI/CT option for identifying whether a patient falls into a high- or low-visceral-fat category. DEXA delivers a fraction of the radiation dose of CT and can be repeated far more affordably than MRI, making it well-suited to the kind of ongoing monitoring a concierge medicine membership in Las Vegas is built around. For very precise tracking of small VAT changes over the course of a specific intervention, MRI still offers more sensitivity, but for the great majority of patients, DEXA with the right software is the right day-to-day tool.
What a Concierge Doctor in Las Vegas Can Do About Excess Visceral Fat
The encouraging news is that visceral fat responds well to targeted intervention. Exercise is the most well-studied approach and can reduce VAT even without weight loss. One meta-analysis found a 6.1% reduction in visceral fat from exercise alone. GLP-1 receptor agonists also produce clinically meaningful VAT reduction, primarily through overall fat loss with relative preservation of lean mass. A concierge doctor in Las Vegas can help you choose, and monitor, the approach that fits your goals and health history.
Frequently Asked Questions About Visceral Fat (VAT)
What does a concierge doctor in Las Vegas do differently from a standard primary care doctor?
A concierge doctor in Las Vegas typically offers longer visits, a smaller patient panel, and interpretation of more advanced diagnostic tools – like DEXA-based body composition scanning – that go well beyond a standard annual physical, including direct measurement of visceral fat rather than relying on BMI alone.
Can a concierge doctor in Las Vegas test my visceral fat level?
Yes. Many concierge practices in Las Vegas, including ours, use DEXA scanning with validated body-composition software to estimate visceral fat directly, rather than relying on waist circumference or BMI alone.
Is visceral fat testing covered by insurance?
Visceral fat-specific imaging is generally not a standard insurance-covered service. That’s one reason concierge medicine membership models, which build these scans into routine care, have become a practical option for Las Vegas patients who want this level of monitoring.
How often should visceral fat be checked?
This varies by individual risk factors and goals. Your concierge doctor in Las Vegas can help determine an appropriate monitoring schedule based on your health history and any interventions you’re pursuing.
The Bottom Line: Finding the Right Concierge Doctor in Las Vegas
Visceral fat is one of the most important and most overlooked numbers in your health picture. If you’ve been focused solely on your weight or BMI, you may be missing the metric that matters most for your heart, your liver, and your long-term cancer risk.
As concierge doctors serving Las Vegas, our practice offers interpretation of DEXA-based visceral fat assessment as part of a broader approach to preventive, personalized care – so you know exactly where you stand, and exactly what to do next.
Sources
Validity of Dual-Energy X-Ray Absorptiometry for Estimation of Visceral Adipose Tissue and Visceral Adipose Tissue Change After Surgery-Induced Weight Loss in Women With Severe Obesity.
Ashby-Thompson, M., Heshka, S., Rizkalla, B., et al. (2022). Obesity.
DXA-derived abdominal adiposity and obesity-related cancer risk among postmenopausal women in the Women’s Health Initiative. Blew, R. M., Ziller, S. G., Odegaard, A. O., et al. (2026). Obesity (Silver Spring).
Assessing Adiposity: A Scientific Statement From the American Heart Association. Cornier, M. A., Després, J. P., Davis, N., et al. (2011). Circulation.
Management of Obesity in Cardiovascular Practice: JACC Focus Seminar. Després, J. P., Carpentier, A. C., Tchernof, A., Neeland, I. J., & Poirier, P. (2021). Journal of the American College of Cardiology.
Visceral Obesity, Metabolic Syndrome, Insulin Resistance and Cancer. Doyle, S. L., Donohoe, C. L., Lysaght, J., & Reynolds, J. V. (2012). Proceedings of the Nutrition Society.
Association of Metabolic Score for Visceral Fat With All-Cause Mortality, Cardiovascular Mortality, and Cancer Mortality: A Prospective Cohort Study. Jia, S., Huo, X., Zuo, X., et al. (2024). Diabetes, Obesity and Metabolism.
Ultrasound and MRI Abdominal Fat Distribution and Its Associations With Metabolic Conditions in Adults With Abdominal Obesity.
Jiménez-Ten Hoevel, C., Besora-Moreno, M., Queral, J., et al. (2026). Diabetes, Obesity and Metabolism.
Contribution of Genetics to Visceral Adiposity and Its Relation to Cardiovascular and Metabolic Disease. Karlsson, T., Rask-Andersen, M., Pan, G., et al. (2019). Nature Medicine.
The Pathophysiology of Visceral Adipose Tissues in Cardiometabolic Diseases. Lee, M. J., & Kim, J. (2024). Biochemical Pharmacology.
Metabolic Effects of a Growth Hormone-Releasing Factor in Obese Subjects With Reduced Growth Hormone Secretion: A Randomized Controlled Trial.
Makimura, H., Feldpausch, M. N., Rope, A. M., et al. (2012). The Journal of Clinical Endocrinology and Metabolism.
Visceral and Ectopic Fat, Atherosclerosis, and Cardiometabolic Disease: A Position Statement. Neeland, I. J., Ross, R., Després, J. P., et al. (2019). The Lancet Diabetes & Endocrinology.
Association Between Visceral Adiposity Index and Cancer Risk in the UK Biobank Cohort. Parra-Soto, S., Boonpor, J., Lynskey, N., et al. (2025). Cancer.
Cross-Sectional Analysis of Visceral Adipose Tissue Associations With Obesity-Related Disease. Potter, A. W., & Friedl, K. E. (2025). American Journal of Clinical Nutrition.
Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association. Powell-Wiley, T. M., Poirier, P., Burke, L. E., et al. (2021). Circulation.
Effect of Tesamorelin on Visceral Fat and Liver Fat in HIV-Infected Patients With Abdominal Fat Accumulation: A Randomized Clinical Trial. Stanley, T. L., Feldpausch, M. N., Oh, J., et al. (2014). Journal of the American Medical Association.
Causes, Consequences, and Treatment of Metabolically Unhealthy Fat Distribution. Stefan, N. (2020). The Lancet Diabetes & Endocrinology.
Accuracy of Dual-Energy X-Ray Absorptiometry for Assessing Longitudinal Change in Visceral Adipose Tissue in Patients With Coronary Artery Disease. Taylor, J. L., Holland, D. J., Coombes, J. S., & Keating, S. E. (2021). International Journal of Obesity.
Revisiting the Obesity Paradox: Visceral Fat Distribution Outperforms BMI in Predicting Mortality and Cardiometabolic Risk. Zhao, M., Chen, H., Zhang, Q., et al. (2026). International Journal of Surgery.